Gladius Capital Management LP - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 8 filers reported holding REGENERON PHARMACEUTICALS in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Gladius Capital Management LP ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q2 2023$21,556,200
-56.3%
30,000
-50.0%
1.05%
-63.3%
Q1 2023$49,300,20060,0002.87%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q2 2024
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 98$4,785,0000.40%
IMC-Chicago, LLC 51,300$25,049,0000.05%
SIMPLEX TRADING, LLC 480$23,437,0000.04%
Focused Wealth Management, Inc 6,400$30,0000.01%
SG Americas Securities, LLC 35,000$642,0000.01%
JPMORGAN CHASE & CO 36,500$17,823,0000.00%
Allianz Asset Management GmbH 4,800$2,344,0000.00%
GROUP ONE TRADING, L.P. 200$98,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders